Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
Many Americans want a different relationship with their doctors that goes beyond treating sickness, according to a recent survey from Samueli Integrative Health Programs.
The FDA granted market clearance to Belgian company Qompium for its FibriCheck phone app, which is expected to launch in the United States market in 2019.
A majority of healthcare providers use clinical decision support (CDS) systems to help them make care decisions for patients, according to a report by Reaction Data.
Patients with mental health conditions had positive perceptions about electronic medical records (EMRs) and physician clinical notes after being given full access to their records, according to a study published in the Annals of Family Medicine.
In a viewpoint article recently published in JAMA, Brigham and Women’s Hospital and Harvard Medical School physicians David W. Bates, MD, Adam Landman, MD, and David M. Levine, MD, argue the Food and Drug Administration (FDA) should develop regulatory policies that ensure the safety and effectiveness of mobile apps.
The healthcare system is accelerating toward a value-based system, but several barriers remain in the way for providers, payers and stakeholders in between.
Penn Medicine recently launched its initiative to “transform” EHRs by making them smarter, streamlined and more interactive—with the ultimate goal of easing the work of clinicians, expediting care and creating the best patient outcomes.
